FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4250770703> ?p ?o ?g. }

• W4250770703 abstract "Schizophrenia is a severe mental disorder with a prevalence of about 1% among the general population. It is listed among the top 10 causes of disability-adjusted life years (DALYs) worldwide. Antipsychotics are the mainstay treatment. Piperacetazine has been reported to be as clinically effective as chlorpromazine, a well established 'benchmark' antipsychotic, for people with schizophrenia. However, the side effect profiles of these antipsychotics differ and it is important that an evidence base is available comparing the benefits, and potential harms of these two antipsychotics.To assess the clinical and side effects of chlorpromazine for people with schizophrenia and schizophrenia-like psychoses in comparison with piperacetazine.We searched the Cochrane Schizophrenia Group's Trials Register (6 June 2015 and 8 October 2018) which is based on regular searches of CINAHL, CENTRAL, BIOSIS, AMED, Embase, PubMed, MEDLINE, PsycINFO and registries of clinical trials. There are no language, date, document type, or publication status limitations for inclusion of records in the register.We included randomised controlled trials (RCTs) focusing on chlorpromazine versus piperacetazine for people with schizophrenia, reporting useable data.We extracted data independently. For binary outcomes, we calculated risk ratio (RR) and its 95% confidence interval (CI), on an intention-to-treat basis. For continuous data, we estimated the mean difference (MD) between groups and its 95% CI. We employed a fixed-effect model for analyses. We assessed risk of bias for included studies and created 'Summary of findings' tables using GRADE.We found 12 records referring to six trials. We included five trials, all from the 1970s, randomising 343 participants. We excluded one trial. The overall methodology and data reporting by the trials was poor. Only short-term data were available.Results from the included trials found that, in terms of global state improvement, when rated by a psychiatrist, there was no clear difference between chlorpromazine and piperacetazine (RR 0.90, 95% CI 0.80 to 1.02; participants = 208; studies = 2; very low-quality evidence). One trial reported change scores on the mental state scale Brief Psychiatric Rating Scale (BPRS); no clear difference was observed (MD -0.40, 95% CI -1.41 to 0.61; participants = 182; studies = 1; very low-quality evidence). Chlorpromazine appears no worse or better than piperacetazine regarding adverse effects. In both treatment groups, around 60% of participants experienced some sort of adverse effect (RR 1.00, 95% CI 0.75 to 1.33; participants = 74; studies = 3; very low-quality evidence), with approximately 40% of these participants experiencing some parkinsonism-type movement disorder (RR 0.95, CI 0.61 to 1.49; participants = 106; studies = 3; very low-quality evidence). No clear difference in numbers of participants leaving the study early for any reason was observed (RR 0.50, 95% CI 0.10 to 2.56; participants = 256; studies = 4; very low-quality evidence). No trial reported data for change in negative symptoms or economic costs.The results of this review show chlorpromazine and piperacetazine may have similar clinical efficacy, but data are based on very small numbers of participants and the evidence is very low quality. We can not make firm conclusions based on such data. Currently, should clinicians and people with schizophrenia need to choose between chlorpromazine and piperacetazine they should be aware there is no good quality evidence to base decisions. More high quality research is needed." @default.
• W4250770703 created "2022-05-12" @default.
• W4250770703 creator A5056396959 @default.
• W4250770703 creator A5058033707 @default.
• W4250770703 creator A5064329544 @default.
• W4250770703 creator A5077417154 @default.
• W4250770703 date "2018-10-31" @default.
• W4250770703 modified "2023-10-17" @default.
• W4250770703 title "Chlorpromazine versus piperacetazine for schizophrenia" @default.
• W4250770703 cites W1591259115 @default.
• W4250770703 cites W1742833546 @default.
• W4250770703 cites W1787568865 @default.
• W4250770703 cites W1795981506 @default.
• W4250770703 cites W1897140431 @default.
• W4250770703 cites W1910485579 @default.
• W4250770703 cites W1964162160 @default.
• W4250770703 cites W1975916217 @default.
• W4250770703 cites W1977185679 @default.
• W4250770703 cites W1978040764 @default.
• W4250770703 cites W1981633279 @default.
• W4250770703 cites W1989405621 @default.
• W4250770703 cites W1991979237 @default.
• W4250770703 cites W1992857340 @default.
• W4250770703 cites W2011130500 @default.
• W4250770703 cites W2020844317 @default.
• W4250770703 cites W2023839473 @default.
• W4250770703 cites W2032712358 @default.
• W4250770703 cites W2040353650 @default.
• W4250770703 cites W2058874144 @default.
• W4250770703 cites W2062836750 @default.
• W4250770703 cites W2075153233 @default.
• W4250770703 cites W2094978143 @default.
• W4250770703 cites W2106848296 @default.
• W4250770703 cites W2114678425 @default.
• W4250770703 cites W2115058221 @default.
• W4250770703 cites W2125435699 @default.
• W4250770703 cites W2130235475 @default.
• W4250770703 cites W2135029321 @default.
• W4250770703 cites W2135494292 @default.
• W4250770703 cites W2138051614 @default.
• W4250770703 cites W2149288810 @default.
• W4250770703 cites W2152689475 @default.
• W4250770703 cites W2157823046 @default.
• W4250770703 cites W2166739899 @default.
• W4250770703 cites W2399793485 @default.
• W4250770703 cites W2416793074 @default.
• W4250770703 cites W2474784003 @default.
• W4250770703 cites W2516970163 @default.
• W4250770703 cites W2765221357 @default.
• W4250770703 cites W2767701264 @default.
• W4250770703 cites W2887644279 @default.
• W4250770703 cites W4230406515 @default.
• W4250770703 cites W4230694669 @default.
• W4250770703 cites W4245828336 @default.
• W4250770703 cites W4250770703 @default.
• W4250770703 cites W4255369243 @default.
• W4250770703 cites W4320288061 @default.
• W4250770703 cites W1675430428 @default.
• W4250770703 doi "https://doi.org/10.1002/14651858.cd011709.pub2" @default.
• W4250770703 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30378678" @default.
• W4250770703 hasPublicationYear "2018" @default.
• W4250770703 type Work @default.
• W4250770703 citedByCount "7" @default.
• W4250770703 countsByYear W42507707032017 @default.
• W4250770703 countsByYear W42507707032018 @default.
• W4250770703 countsByYear W42507707032020 @default.
• W4250770703 countsByYear W42507707032021 @default.
• W4250770703 crossrefType "journal-article" @default.
• W4250770703 hasAuthorship W4250770703A5056396959 @default.
• W4250770703 hasAuthorship W4250770703A5058033707 @default.
• W4250770703 hasAuthorship W4250770703A5064329544 @default.
• W4250770703 hasAuthorship W4250770703A5077417154 @default.
• W4250770703 hasBestOaLocation W42507707032 @default.
• W4250770703 hasConcept C118552586 @default.
• W4250770703 hasConcept C126322002 @default.
• W4250770703 hasConcept C17744445 @default.
• W4250770703 hasConcept C187212893 @default.
• W4250770703 hasConcept C199539241 @default.
• W4250770703 hasConcept C27415008 @default.
• W4250770703 hasConcept C2776412080 @default.
• W4250770703 hasConcept C2776619155 @default.
• W4250770703 hasConcept C2778775820 @default.
• W4250770703 hasConcept C2779473830 @default.
• W4250770703 hasConcept C2779549880 @default.
• W4250770703 hasConcept C2780494398 @default.
• W4250770703 hasConcept C2781145037 @default.
• W4250770703 hasConcept C2908647359 @default.
• W4250770703 hasConcept C44249647 @default.
• W4250770703 hasConcept C535046627 @default.
• W4250770703 hasConcept C71924100 @default.
• W4250770703 hasConcept C82789193 @default.
• W4250770703 hasConcept C95190672 @default.
• W4250770703 hasConcept C99454951 @default.
• W4250770703 hasConceptScore W4250770703C118552586 @default.
• W4250770703 hasConceptScore W4250770703C126322002 @default.
• W4250770703 hasConceptScore W4250770703C17744445 @default.
• W4250770703 hasConceptScore W4250770703C187212893 @default.
• W4250770703 hasConceptScore W4250770703C199539241 @default.
• W4250770703 hasConceptScore W4250770703C27415008 @default.
• W4250770703 hasConceptScore W4250770703C2776412080 @default.

• next